Both in Pharmaceuticals
Structure Therapeutics vs Zai Lab Limited
Over the past year GPCR returned +29.2% and ZLAB returned −21.3%; their daily moves had a correlation of 0.09.
GPCR +29.2% ZLAB −21.3%Growth of $1, one year, split-adjusted
| Metric | GPCR | ZLAB |
|---|---|---|
| Price | $32.69 | $25.93 |
| Market cap | $2.33B | $2.91B |
| Today | −6.77% | +0.93% |
| 1 month | −31.0% | −0.6% |
| 6 months | −25.6% | +45.3% |
| Year to date | −53.0% | +47.0% |
| 1 year | +30.8% | −18.0% |
| Revenue growth (YoY) | — | −3.3% |
| Gross margin | — | 54.7% |
| Net margin | — | −47.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.5× |
| Net cash | $1.34B | $379.4M |
| Dividend yield | — | — |
| Volatility (60d) | 57.3% | 53.2% |
| Short % of float | — | — |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).